Summary:
A Phase 2b, Randomized, Double Blind, Two Arm Study to Investigate the Effects of BNC210 Tablet Formulation Compared to Placebo in Adults With Post-Traumatic Stress Disorder (PTSD)
Criteria:- Be 18-75 years old
- Be experiencing symptoms of PTSD due to a traumatic event that occurred after the age 18
- Not be a member of the United States military currently serving on active duty
- Additional criteria apply
Qualified Participants May Receive:
- Study-related care at no cost
- Compensation up to $750 for time and trial-related travel expenses
- No insurance needed and transportation available